No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs13110208 |
chr4:7353052-7353053 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs565839731 |
chr4:7353066-7353067 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs183844906 |
chr4:7353089-7353090 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs554758536 |
chr4:7353093-7353094 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs576203687 |
chr4:7353126-7353127 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs543589575 |
chr4:7353127-7353128 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs559023930 |
chr4:7353171-7353172 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs577459950 |
chr4:7353198-7353199 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs371051208 |
chr4:7353245-7353246 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs188340036 |
chr4:7353271-7353272 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs560043925 |
chr4:7353308-7353309 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs192443571 |
chr4:7353322-7353323 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs141249175 |
chr4:7353337-7353338 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs561086794 |
chr4:7353373-7353374 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs531562800 |
chr4:7353387-7353388 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs532161913 |
chr4:7353410-7353411 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs566929131 |
chr4:7353411-7353412 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs534050055 |
chr4:7353418-7353419 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs148794358 |
chr4:7353436-7353437 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs76181180 |
chr4:7353437-7353438 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs549932470 |
chr4:7353443-7353444 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs183786438 |
chr4:7353450-7353451 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs187641279 |
chr4:7353467-7353468 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs374292820 |
chr4:7353482-7353483 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs547484281 |
chr4:7353497-7353498 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs565704845 |
chr4:7353519-7353520 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs536369307 |
chr4:7353545-7353546 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs554674384 |
chr4:7353602-7353603 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs376095144 |
chr4:7353610-7353611 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs569801649 |
chr4:7353726-7353727 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs537289811 |
chr4:7353743-7353744 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs559106555 |
chr4:7353744-7353745 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs562610275 |
chr4:7353753-7353754 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs541666752 |
chr4:7353767-7353768 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs368494308 |
chr4:7353850-7353851 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs553502181 |
chr4:7353891-7353892 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs572040966 |
chr4:7353893-7353894 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs542622570 |
chr4:7353913-7353914 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs560999675 |
chr4:7353934-7353935 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs531425140 |
chr4:7353956-7353957 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs117234230 |
chr4:7354062-7354063 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs565050685 |
chr4:7354086-7354087 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs532321091 |
chr4:7354147-7354148 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs547643618 |
chr4:7354149-7354150 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs191347326 |
chr4:7354194-7354195 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs183492416 |
chr4:7354204-7354205 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs548170318 |
chr4:7354208-7354209 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs60030877 |
chr4:7354224-7354225 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs150784648 |
chr4:7354245-7354246 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs552502993 |
chr4:7354251-7354252 |
Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|